Mumbai, Maharashtra, 12th of October, 2026 : Sahajanand Medical Technologies Limited, a company that has established a strong reputation for innovation in advanced medical technology and cardiovascular treatment, is now set to begin a new chapter in the stock market. The company’s Initial Public Offering (IPO) will open on October 15, 2026, and investors can place their bids until October 19. The price band has been fixed at ₹327 to ₹344 per equity share, with a minimum application size of 43 shares.
The IPO comprises entirely an Offer for Sale (OFS) of more than 1.38 crore shares. This means the proceeds from the issue will go to the selling shareholders rather than to the company. The company has proposed to list its shares on the National Stock Exchange (NSE) and the BSE.
Founded in 1999, the company has established a strong presence in the field of advanced medical devices, including stents, drug-coated balloons, and devices used in structural heart interventions. Its key strengths include a strong focus on research and development and the ability to develop advanced technologies tailored to patients’ needs. The company holds an approximately 25% market share in the drug-eluting stent segment. In FY2026, its revenue from operations increased to ₹1,210.50 crore, while its net profit reached ₹69.08 crore.
More Stories
Durga Puja Pandal To Reflect The Grandeur Of Kerala’s Iconic Temple.
Can Liver Cancer Develop Without Symptoms? The Silent Signs You Should Know.
Jetwerk IPO Opens On October 15, Offering Investors An Opportunity To Subscribe Until October 19.